Skip to main content
OpenTrials
Completed

NCT Number: NCT00046137

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

The purpose of this study is to compare treatment with both teriparatide and raloxifene with teriparatide alone. The study will evaluate any side effects that may be associated with the two drugs and may help to determine whether teriparatide and raloxifene together can help patients with osteoporosis more than teriparatide alone.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoporosis, Postmenopausal Bone Diseases Bone Diseases, Metabolic Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases Osteoporosis

Age range

45 year–85 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

"For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician"., Anaheim, California, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must be diagnosed with osteoporosis.
  • Must be female, age 45 through 85.
  • Must be at least 5 years postmenopausal.
  • Must be free of other severe or chronically disabling conditions.
  • Must be able to properly use injection device.

Exclusion criteria

  • Must not have bone diseases other than osteoporosis.
  • Must not have history of certain cancers.
  • Must not have certain medical diseases (inflammatory bowel disease, malabsorption syndrome, kidney or bladder stones, venous thrombi or emboli, recent vaginal bleeding due to unknown causes).
  • Must not have taken or are currently taking certain types of medicines.
  • Must not have known allergy to the study agent or SERM.

Treatment and study plan

Teriparatide

Drug

Raloxifene

Drug

Placebo

Drug

Sponsors and collaborators

Lead sponsor

Eli Lilly and Company

Industry

Registry information

Important dates

First posted
Sep 23, 2002
Registry last updated
Jul 20, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.